• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how to get adhd medication without diagnosis long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological developmental disorders like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to evaluate the benefits of using it against the potential risks to the baby. The doctors don't have the information to provide clear recommendations but they can provide information on the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not have a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to ensure that the classification was accurate and to reduce any bias.

The study conducted by the researchers had some limitations. In particular, they were not able to differentiate the effects of the medication from the effects of the disorder that is underlying. This makes it difficult for researchers to determine if the few associations observed between the groups that were exposed to medication use or if they were caused by co-morbidities. Researchers also did not look at long-term outcomes for offspring.

The study showed that infants whose mothers took ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or stopped taking their medication before or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean section or having a baby with low Apgar score (less than 7). These risks did not seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications during early pregnancies may be offset by the greater benefits for mother and baby from continuing treatment for the woman’s disorder. Physicians should talk to their patients about this and as much as possible, assist them develop coping skills that can lessen the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the question of whether to keep or stop treatment during pregnancy is one that more and more doctors face. Most of the time, these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors have to weigh their experience about their experiences, the experiences of other doctors, and what the research suggests about the subject, along with their best judgment for each patient.

Particularly, the subject of possible risks to the infant can be difficult. Many studies on this subject are based on observations rather than controlled research and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which could undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study presented in this journal club addresses these limitations by examining data on both live and deceased births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show a neutral, or even somewhat negative, effect. Therefore, a careful risk/benefit assessment must be conducted in every case.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In fact, in an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can adhd medication help with memory increase depression, feelings of loneliness and family conflict for those suffering from the disorder. The loss of medication can also impact the ability to drive safely and to perform work-related tasks which are vital aspects of normal life for people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy should educate family members, colleagues, and acquaintances about the condition, the impact on daily functioning and the benefits of keeping the current treatment plan. It can also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If a woman decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the medication could be passed on to her baby.

Birth Defects Risk

As the use of ADHD medications to treat adhd without medication adults symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about the effects that the medications could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Researchers used two huge data sets to examine more than 4.3 million pregnancy and determine if stimulant medication use increased the risk of birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study did not discover any link between early medication usage and other congenital anomalies like facial deformities, or club feet. The results are in line with previous studies that showed an insignificant, but small increase in cardiac malformations for women who began taking ADHD medication prior to the time of the time of pregnancy. The risk was higher in the later part of pregnancy, when a lot of women decide to stop taking their ADHD medications.

Women who took ADHD medications in the first trimester of pregnancy were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby who required help breathing at birth. However the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have other medical issues that could have contributed to these findings.

Researchers hope their research will inform physicians when they meet pregnant women. The researchers advise that while discussing benefits and risks are important, the choice about whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors warn that, while stopping the medication is an option to look into, it is not recommended due to the high prevalence of depression and other mental disorders for women who are pregnant or recently gave birth. Furthermore, research suggests that women who decide to stop taking their medications are more likely how to get adhd meds without diagnosis have difficulties getting used to life without them following the birth of their baby.

Nursing

It can be overwhelming becoming a mother. Women who suffer from ADHD who must work through their symptoms while attending physician appointments as well as making preparations for the arrival of a child and adapting to new routines in the home may face a lot of challenges. Therefore, many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at low levels. However, the rate of exposure to medications by the newborn may differ based on dosage, frequency it is taken and the time of day it is administered. In addition, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't fully understood.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the benefits of continuing her medication against the potential risks to the embryo. As long as there is no more information, doctors should inquire with all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal period.

Many studies have shown that women can continue to take their ADHD medication in a safe manner during pregnancy and breast-feeding. In response, a growing number of patients are opting to do so. They have found after consulting with their doctor that the benefits of continuing their current medication far outweigh any risk.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from Adhd Medication pregnancy be aware of the symptoms and the underlying disorder. They should also be educated about treatment options and strengthen coping mechanisms. This should be a multidisciplinary effort together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, as well as monitoring for indicators of deterioration, and, if necessary adjustments to the medication regime.